spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  VIOXX 

 HSMN NewsFeed - 17 Jul 2008
Merck to Fund U.S. VIOXX(R) Product Liability Resolution Program
Biopharmaceuticals Litigation
 HSMN NewsFeed - 30 May 2008
Merck Wins Appeal of First VIOXX(R) Case to go to Trial
Biopharmaceuticals Litigation
 HSMN NewsFeed - 29 May 2008
Merck Wins Appeal of First VIOXX(R) Case to go to Trial
Biopharmaceuticals Litigation
 HSMN NewsFeed - 20 May 2008
Merck Resolves Investigations Under State Consumer Protection Statutes Related to VIOXX
Biopharmaceuticals Litigation
 HSMN NewsFeed - 15 Apr 2008
Merck Responds to Journal of the American Medical Association Articles
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2008
Stem Cell Technology Offers Promise of Huge Savings for Drug Developers
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 7 Mar 2008
In Post-Vioxx Era, Biologics Are Reviving Arthritis Treatment Market
Biopharmaceuticals
 HSMN NewsFeed - 7 Feb 2008
Merck Resolves Federal and State Investigations Related to Certain Past Pricing And Certain Past Sales and Marketing Activities
Biopharmaceuticals
 HSMN NewsFeed - 6 Sep 2007
New Jersey High Court Denies Nationwide Class-Action Status to Insurance Companies Seeking VIOXX(R) Reimbursements
Biopharmaceuticals Litigation
 HSMN NewsFeed - 26 Jul 2007
Merck Names Kenneth C. Frazier as President, Global Human Health
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2007
Federal Court Dismisses VIOXX(R) Securities Class Action
Biopharmaceuticals Litigation
 HSMN NewsFeed - 23 Mar 2007
Amira Pharmaceuticals Raises $25 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Mar 2007
N.J. VIOXX(R) Product Liability Trial Proceeds to Second Phase
Biopharmaceuticals Litigation
 HSMN NewsFeed - 22 Jan 2007
Plaintiff Drops VIOXX(R) Suit against Merck Five Weeks Before First Trial in Philadelphia State Court
Biopharmaceuticals Litigation
 HSMN NewsFeed - 18 Jan 2007
VIOXX(R) Plaintiffs Failed to Prove Their Cases
Biopharmaceuticals Litigation
 HSMN NewsFeed - 8 Jan 2007
Horizon Therapeutics Announces Special Protocol Assessment With FDA for Phase 3 Trial Program
Biopharmaceuticals
 HSMN NewsFeed - 15 Dec 2006
Merck Wins Alabama VIOXX(R) Product Liability Case
Biopharmaceuticals Litigation
 HSMN NewsFeed - 13 Dec 2006
Merck Wins Federal VIOXX(R) Product Liability Case
Biopharmaceuticals Litigation
 HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals
 HSMN NewsFeed - 22 Nov 2006
Statement Regarding Dismissal of Personal Injury Class-Action Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 15 Nov 2006
Merck Wins Federal VIOXX(R) Product Liability Case
Biopharmaceuticals Litigation
 HSMN NewsFeed - 13 Jul 2006
Merck Wins New Jersey VIOXX(R) Product Liability Case
Biopharmaceuticals Litigation
 HSMN NewsFeed - 26 Jun 2006
Merck Stands Behind Original APPROVe Study Results
Biopharmaceuticals
 HSMN NewsFeed - 30 May 2006
Merck Corrects Description of a Statistical Method Used in APPROVe Study
Biopharmaceuticals
 HSMN NewsFeed - 11 May 2006
Merck Announces Preliminary Analyses of Off-Drug Extension of APPROVe Study
Biopharmaceuticals Oncology Cardiology
Return to NewsFeed  

 Additional items found! 48

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 48 additional stories matching:
VIOXX
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.